NCT06436950

Brief Summary

This study aims to examine efficacy of transcutaneous electrical phrenic nerve stimulation (TEPNS) in ventilator-induced diaphragmatic dysfunction (VIDD). The investigators recruit VIDD patients, and randomly assign the patients into TEPNS group and control group. TEPNS group receives TEPNS twice a day for consecutive 5 days. Control group only receives usual care. The investigators collect diaphragm function indicators and outcomes to evaluate the efficacy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 31, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

June 4, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

November 12, 2024

Status Verified

June 1, 2024

Enrollment Period

1.5 years

First QC Date

May 20, 2024

Last Update Submit

November 10, 2024

Conditions

Keywords

Ventilator-induced diaphragmatic dysfunctiontranscutaneous electrical phrenic nerve stimulation

Outcome Measures

Primary Outcomes (1)

  • Transdiaphragmatic pressure (Pdi)

    Pdi=gastric pressure - esophageal pressure

    Collected once a day after transcutaneous electrical phrenic nerve stimulation (TEPNS) for consecutive 5 days

Secondary Outcomes (5)

  • Airway pressure, esophageal pressure, gastric pressure, airway occlusion pressure, driving pressure, transpulmonary pressure

    Collected once a day after TEPNS for consecutive 5 days

  • Esophageal pressure-time product

    Collected once a day after TEPNS for consecutive 5 days

  • Ventilation days

    Collected at 28 days after enrollment

  • Length of ICU stay

    Collected at 28 days after enrollment

  • 28-day mortality

    Collected at 28 days after enrollment

Study Arms (2)

transcutaneous electrical phrenic nerve stimulation (TEPNS) group

EXPERIMENTAL

The patients in TEPNS group receive TEPNS and usual care.

Device: transcutaneous electrical phrenic nerve stimulation (TEPNS)

Control group

NO INTERVENTION

The patients in control group receive usual care only.

Interventions

TEPNS is conducted twice a day for consecutive 5 days. Electrodes are applied to bilateral neck skin which phrenic nerve runs underneath.

transcutaneous electrical phrenic nerve stimulation (TEPNS) group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged ≥ 18 years
  • ventilated for at least 48 h with an expected stay of more than 7 days in the ICU
  • diaphragm thickening fraction (DTF)\< 25%

You may not qualify if:

  • having a pacemaker
  • cutaneous lesion that could interfere with probes
  • previous diaphragmatic nerve paralysis
  • body mass index \> 35 kg/m2
  • severe chronic obstructive pulmonary disease (FEV1/FVC\<30%)
  • pregnancy or lactation
  • decision to withhold life-sustaining treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

RECRUITING

Related Publications (6)

  • Bao Q, Chen L, Chen X, Li T, Xie C, Zou Z, Huang C, Zhi Y, He Z. The effects of external diaphragmatic pacing on diaphragm function and weaning outcomes of critically ill patients with mechanical ventilation: a prospective randomized study. Ann Transl Med. 2022 Oct;10(20):1100. doi: 10.21037/atm-22-4145.

    PMID: 36388825BACKGROUND
  • Medrinal C, Machefert M, Lamia B, Bonnevie T, Gravier FE, Hilfiker R, Prieur G, Combret Y. Transcutaneous electrical diaphragmatic stimulation in mechanically ventilated patients: a randomised study. Crit Care. 2023 Aug 30;27(1):338. doi: 10.1186/s13054-023-04597-1.

    PMID: 37649092BACKGROUND
  • O'Rourke J, Sotak M, Curley GF, Doolan A, Henlin T, Mullins G, Tyll T, Omlie W, Ranieri MV. Initial Assessment of the Percutaneous Electrical Phrenic Nerve Stimulation System in Patients on Mechanical Ventilation. Crit Care Med. 2020 May;48(5):e362-e370. doi: 10.1097/CCM.0000000000004256.

    PMID: 32191413BACKGROUND
  • Sotak M, Roubik K, Henlin T, Tyll T. Phrenic nerve stimulation prevents diaphragm atrophy in patients with respiratory failure on mechanical ventilation. BMC Pulm Med. 2021 Oct 8;21(1):314. doi: 10.1186/s12890-021-01677-2.

    PMID: 34625059BACKGROUND
  • Poulard T, Bachasson D, Fosse Q, Nierat MC, Hogrel JY, Demoule A, Gennisson JL, Dres M. Poor Correlation between Diaphragm Thickening Fraction and Transdiaphragmatic Pressure in Mechanically Ventilated Patients and Healthy Subjects. Anesthesiology. 2022 Jan 1;136(1):162-175. doi: 10.1097/ALN.0000000000004042.

    PMID: 34788380BACKGROUND
  • Goligher EC, Dres M, Patel BK, Sahetya SK, Beitler JR, Telias I, Yoshida T, Vaporidi K, Grieco DL, Schepens T, Grasselli G, Spadaro S, Dianti J, Amato M, Bellani G, Demoule A, Fan E, Ferguson ND, Georgopoulos D, Guerin C, Khemani RG, Laghi F, Mercat A, Mojoli F, Ottenheijm CAC, Jaber S, Heunks L, Mancebo J, Mauri T, Pesenti A, Brochard L. Lung- and Diaphragm-Protective Ventilation. Am J Respir Crit Care Med. 2020 Oct 1;202(7):950-961. doi: 10.1164/rccm.202003-0655CP.

    PMID: 32516052BACKGROUND

Study Officials

  • Zongyu Wang, Dr.

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zongyu Wang, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Transcutaneous electrical phrenic nerve stimulation (TEPNS) group: TEPNS+usual care Control group: usual care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 20, 2024

First Posted

May 31, 2024

Study Start

June 4, 2024

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

November 12, 2024

Record last verified: 2024-06

Locations